Hyperglycemia and Advanced Glycation End Products (AGEs) Suppress the Differentiation of 3T3-L1 Preadipocytes

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Sep 15

PMID 28903400

Citations 13

Authors

Chia-Chu Chang

Chen-Yu Chen

Geen-Dong Chang

Ting-Huan Chen

Woan-Ling Chen

Hui-Chin Wen

Chih-Yang Huang

Chung-Ho Chang

Affiliations

Soon will be listed here.

Abstract

Aging is characterized by mild hyperglycemia and accumulation of advanced glycation end products (AGEs). Effects of chronic exposure to hyperglycemia or AGEs on the adipogenic differentiation of 3T3-L1 preadipocytes remain unclear. We examined the chronic effect of AGEs and high glucose on the differentiation of 3T3-L1 cells by culturing 3T3-L1 cells in the presence of AGEs or 25 mM glucose for 1 month. Chronic incubation of 3T3-L1 cells with AGEs or high glucose blocked their differentiation into mature adipocytes as evidenced by reduced levels of adipocyte markers such as accumulated oil droplets, GPDH, aP2, adiponectin and of adipogenesis regulators PPARγ and C/EBPα. Levels or activities of Src, PDK1, Akt, and NF-κB were higher in AGEs- and high glucose-treated cells than those in 3T3-L1 cells. Levels of Bcl-2 were elevated in AGEs- and high glucose-treated cells, and were attenuated by inhibitors of PI3-kinase, Akt and NF-κB. Moreover, adipogenesis was attenuated in 3T3-L1 cells stably expressing Bcl-2 or YAP. These results suggest that chronic AGEs and high glucose treatments up-regulate Bcl-2 and YAP via the Akt-NF-κB pathway and impair adipogenesis.

Citing Articles

Interplay of Glucose Metabolism and Hippo Pathway in Chondrocytes: Pathophysiology and Therapeutic Targets.

Jahn J, Ehlen Q, Kaplan L, Best T, Meng Z, Huang C Bioengineering (Basel). 2024; 11(10).

PMID: 39451348 PMC: 11505586. DOI: 10.3390/bioengineering11100972.

Dietary advanced glycation end-products and their associations with body weight on a Mediterranean diet and low-fat vegan diet: a randomized, cross-over trial.

Kahleova H, Znayenko-Miller T, Motoa G, Eng E, Prevost A, Uribarri J Front Nutr. 2024; 11:1426642.

PMID: 39176029 PMC: 11340516. DOI: 10.3389/fnut.2024.1426642.

Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Gene Expression in 3T3-L1 Adipocytes.

Michalani M, Passarelli M, Machado U Int J Mol Sci. 2024; 25(15).

PMID: 39125811 PMC: 11311564. DOI: 10.3390/ijms25158242.

Novel Properties of Old Propranolol-Assessment of Antiglycation Activity through and Approaches.

Lauko K, Nesterowicz M, Trocka D, Dankowska K, Zendzian-Piotrowska M, Zalewska A ACS Omega. 2024; 9(25):27559-27577.

PMID: 38947802 PMC: 11209686. DOI: 10.1021/acsomega.4c03025.

Mechanobiology-informed biomaterial and tissue engineering strategies for influencing skeletal stem and progenitor cell fate.

Woodbury S, Swanson W, Mishina Y Front Physiol. 2023; 14:1220555.

PMID: 37520820 PMC: 10373313. DOI: 10.3389/fphys.2023.1220555.

References

Freytag S, Paielli D, Gilbert J . Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 1994; 8(14):1654-63. DOI: 10.1101/gad.8.14.1654. View

Wise L, Green H . Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J Biol Chem. 1979; 254(2):273-5. View

Kane L, SHAPIRO V, Stokoe D, Weiss A . Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol. 1999; 9(11):601-4. DOI: 10.1016/s0960-9822(99)80265-6. View

Thomas M, Forbes J, Cooper M . Advanced glycation end products and diabetic nephropathy. Am J Ther. 2005; 12(6):562-72. DOI: 10.1097/01.mjt.0000178769.52610.69. View

Gagnon A, Sorisky A . The effect of glucose concentration on insulin-induced 3T3-L1 adipose cell differentiation. Obes Res. 1998; 6(2):157-63. DOI: 10.1002/j.1550-8528.1998.tb00330.x. View

Chen Z, Vetter M, Chang G, Liu S, Che D, Ding Y . Cyclophilin A functions as an endogenous inhibitor for membrane-bound guanylate cyclase-A. Hypertension. 2004; 44(6):963-8. DOI: 10.1161/01.HYP.0000145859.94894.23. View

Spencer N, Poynter M, Im S, Daynes R . Constitutive activation of NF-kappa B in an animal model of aging. Int Immunol. 1997; 9(10):1581-8. DOI: 10.1093/intimm/9.10.1581. View

Grillo M, Colombatto S . Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases. Amino Acids. 2007; 35(1):29-36. DOI: 10.1007/s00726-007-0606-0. View

Zhang H, Pasolli H, Fuchs E . Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc Natl Acad Sci U S A. 2011; 108(6):2270-5. PMC: 3038759. DOI: 10.1073/pnas.1019603108. View

10.

Neese R, Misell L, Turner S, Chu A, Kim J, Cesar D . Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A. 2002; 99(24):15345-50. PMC: 137719. DOI: 10.1073/pnas.232551499. View

11.

Rosen E, Sarraf P, Troy A, Bradwin G, Moore K, Milstone D . PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999; 4(4):611-7. DOI: 10.1016/s1097-2765(00)80211-7. View

12.

Barak Y, Nelson M, Ong E, Jones Y, Ruiz-Lozano P, Chien K . PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999; 4(4):585-95. DOI: 10.1016/s1097-2765(00)80209-9. View

13.

Huffman D, Barzilai N . Role of visceral adipose tissue in aging. Biochim Biophys Acta. 2009; 1790(10):1117-23. PMC: 2779572. DOI: 10.1016/j.bbagen.2009.01.008. View

14.

Bohlender J, Franke S, Stein G, Wolf G . Advanced glycation end products and the kidney. Am J Physiol Renal Physiol. 2005; 289(4):F645-59. DOI: 10.1152/ajprenal.00398.2004. View

15.

Chen Y, Chen C, Hsu Y, Chen T, Sue Y, Cheng C . Leptin reduces gentamicin-induced apoptosis in rat renal tubular cells via the PI3K-Akt signaling pathway. Eur J Pharmacol. 2011; 658(2-3):213-8. DOI: 10.1016/j.ejphar.2011.02.025. View

16.

Arcaro A, Aubert M, Espinosa del Hierro M, Khanzada U, Angelidou S, Tetley T . Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling. Cell Signal. 2007; 19(5):1081-92. DOI: 10.1016/j.cellsig.2006.12.003. View

17.

Ahmed N, Thornalley P . Advanced glycation endproducts: what is their relevance to diabetic complications?. Diabetes Obes Metab. 2007; 9(3):233-45. DOI: 10.1111/j.1463-1326.2006.00595.x. View

18.

Wang N, Finegold M, Bradley A, Ou C, Abdelsayed S, Wilde M . Impaired energy homeostasis in C/EBP alpha knockout mice. Science. 1995; 269(5227):1108-12. DOI: 10.1126/science.7652557. View

19.

Jin Y, Fishbein M, Said J, Jindra P, Rajalingam R, Rozengurt E . Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol. 2004; 65(4):291-302. DOI: 10.1016/j.humimm.2004.01.002. View

20.

Unoki H, Bujo H, Yamagishi S, Takeuchi M, Imaizumi T, Saito Y . Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res Clin Pract. 2006; 76(2):236-44. DOI: 10.1016/j.diabres.2006.09.016. View